Robert H. Pudenz award
Awarding excellence in cerebrospinal fluid and hydrocephalus research
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Awarding excellence in cerebrospinal fluid and hydrocephalus research
The development of cutting-edge medical technology, as well as the improvement of existing products, is a collaborative process between medical device companies, physicians, and medical institutions. Medtronic is committed to continuing collaboration with physicians and their institutions in the form of donations of money and other types of sponsorships, such as programs designed to educate and train physicians to allow them and their institutions to bring life-saving and life-enhancing therapies to patients worldwide.
The Pudenz Award is a research grant awarded to the academic or clinical institution with which the nominee is affiliated, demonstrating a commitment to advancing the science of the field of CSF physiology and hydrocephalus through research published in peer-reviewed journals. The recipient of the award is chosen by an independent Committee based on the extensive nature of the research work conducted by the recipient.
The award has been given since 1988 in honor of Robert H. Pudenz, one of the founders of the PS Medical Corporation (now Medtronic). He was a recognized pioneer in the field of pediatric neurosurgery. His area of research was in cerebrospinal fluid physiology and shunt technology for the treatment of hydrocephalus.
Image credit: HMRI.org
Professor Roger Bayston, from the School of Medicine, Biomaterials-Related Infection Group, University of Nottingham, has made many contributions to developing and understanding the value of antibiotic-impregnated hydrocephalus shunt catheters. These local and international contributions have helped move awareness of the significance of shunt infection forward in the medical community. A review of his publications by the Pudenz Award Selection Committee confirmed the seminal role Prof. Bayston has played in the development of antibiotic-impregnated catheters and their value in the treatment of shunt infection, significantly lowering shunt infections and improving the quality of life for thousands of patients. The value of his findings has been proven in several controlled trial studies.
Year | Awardee | Country |
---|---|---|
2020 | Jan Malm, Ph.D.. & Anders Eklund, Ph.D. | Sweden |
2017 | Carsten Wikkelslo | Sweden |
2015 | Michael Williams | United States |
2013 | John R.W. Kestle, M.D. | United States |
2011 | Esteban M. Rodriguez, M.D., Ph.D. | Chile |
2010 | Marek Czosnyka, Ph.D. | United Kingdom |
2009 | Marc R. Del Bigio, M.D., Ph.D. | Canada |
2008 | Anthony Marmarou, Ph.D. | United States |
2007 | Hazel Cordelia Jones, Ph.D. | United Kingdom |
2006 | Miles Gregory Johnston, Ph.D. | Canada |
2005 | James Patterson McAllister II, Ph.D. | United States |
2004 | Conrad Earl Johanson, Ph.D. | United States |
2003 | Salomon Hakin, M.D. | Colombia |
2002 | Sven Erik Borgensen, M.D. | Denmark |
2001 | Kiyoshi Sato, M.D. | Japan |
2000 | John D. Pickard, M.D. | United Kingdom |
1999 | Christian Sainte-Rose, M.D. | France |
1998 | Harold D. Portnoy, M.D. | United States |
1997 | Flemming Gjerris, M.D., DSc | Denmark |
1996 | Concezio Di Rocco, M.D. | Italy |
1995 | David G. McLone, M.D. | United States |
1994 | Bernard Williams, FRCS | United Kingdom |
1994 | Thomas H. Milhorat, M.D. | United States |
1993 | Harold Rekate, M.D. | United States |
1992 | Maurice Choux, M.D. | France |
1991 | Michael Pollay, M.D., FAANS(L) | United States |
1991 | Ismail El Shafei, M.D. | Egypt |
1990 | J. Gordon McComb, M.D. | United States |
1990 | Alfred Aschoff, M.D. | Germany |
1990 | Shizuo Oi, M.D. | Japan |
1990 | Satoshi Matsumoto, M.D. | Japan |
1989 | James Drake, M.D. | Canada |
1988 | Isam Awad, M.D. | United States |
Learn more about Medtronic cerebrospinal fluid (CSF)
shunt products and technology.